Status:
COMPLETED
Prevalence of Deep Sedation in Terminal Palliative Phase
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Palliative Care
Deep Sedations
Eligibility:
All Genders
6+ years
Brief Summary
This nation-wide, multicentric, prospective and cross-sectional study aims to estimate the prevalence of deep sedations (i.e. with a -4 or -5 score at the Richmond scale at the induction time) for pat...
Detailed Description
Inducing a deep sedation in palliative care is a sensitive practice. The abolition of the communication in a crucial moment of life for the patients is particularly challenging. This practice implies ...
Eligibility Criteria
Inclusion
- Major, minor, major with legal protection patient
- Follow-up by a specialized palliative care facility;
- Palliative situation of a disease (non-curable);
- In terminal palliative phase (life expectancy estimated by the investigator =\< 4 weeks)
Exclusion
- Not followed by a specialized palliative care facility;
- In curative situation (curable);
- In non-terminal palliative phase (life expectancy estimated by the investigator \> 4 weeks).
Key Trial Info
Start Date :
September 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 17 2020
Estimated Enrollment :
183 Patients enrolled
Trial Details
Trial ID
NCT04333719
Start Date
September 13 2020
End Date
November 17 2020
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Bordeaux - St André
Bordeaux, Aquitaine, France, 33000